Lv4
470 积分 2024-01-22 加入
207-OR: Myostatin Inhibition Synergizes with GLP-1R Agonism to Accelerate Weight Loss in Male, Obese Nonhuman Primates
3小时前
求助中
A brief review of urate transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia and gout: Current therapeutic options and potential applications
2个月前
已完结
Dissociation Between Clinical Benefit and Persistent Urate Lowering in Patients with Chronic Refractory Gout Treated with Pegloticase
2个月前
已完结
Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment
2个月前
已完结
Pegloticase Treatment Significantly Decreases Blood Pressure in Patients With Chronic Gout
2个月前
已完结
PEG-uricase in the management of treatment-resistant gout and hyperuricemia
2个月前
已完结
Pegloticase in Combination With Methotrexate in Patients With Uncontrolled Gout: A Multicenter, Open-label Study (MIRROR)
2个月前
已完结
First muscle-growing antibody heads to the FDA, with obesity opportunities on the horizon
2个月前
已完结
Emerging therapeutic options for refractory gout
2个月前
已完结
皖公网安备34019202002308
